Tianyin Pharmaceutical Co., Inc. (TPI)
F3Q10 (Qtr End 03/31/10) Earnings Call
May 12, 2010 09:00 am ET
James Jiayuan Tong - CFO, Chief Business & Development Officer
Jiang Guoqing - MD, Chairman and CEO
Jamie Clement - Sidoti
Boyd Heinz - Equinox
Kevin Wood - Baron Partners
Good morning, ladies and gentlemen. Thank you for standing by. Welcome to the Tianyin Pharmaceutical Inc. third quarter fiscal 2010 earnings conference call. At this time, all participants are in a listen-only mode. Following the presentation, we will conduct the question-and-answer session. Instructions will be provided at that time for you to queue up for questions. (Operator Instructions). I would like to remind everyone that this conference call is being recorded today, Wednesday, May 12, 2010, at 9 AM Eastern Time.
I will now turn the conference over to Dr. James Jiayuan Tong, Chief Financial Officer and Chief Business & Development Officer. Please go ahead, sir.
James Jiayuan Tong
Thank you, good morning and good evening. Ladies and gentlemen, welcome to Tianyin Pharmaceutical third quarter fiscal 2010 earnings conference call. I am James Jiayuan Tong, Chief Financial Officer and Chief Business & Development Officer of Tianyin Pharmaceutical, along with Dr. Jiang Guoqing, Chief Executive Officer of the company; Mr. Li Hongcai, Vice President of Investor Relations of the company.
During this conference call, we'll be reviewing the third quarter financial highlights followed by a question-and-answer period. Before we continue, please note that this call will contain forward-looking statements made under the Safe Harbor provisions of the US Private Security Litigation Reform Act of 1995.